APA (7th ed.) Citation

K, J., S, Y., SE, K., JY, C., SH, Y., KS, L., . . . H, L. (2014, June). Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state. Drug Design, Development and Therapy.

Chicago Style (17th ed.) Citation

K, Jang, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, and Lee H. "Novel Nanocrystal Formulation of Megestrol Acetate Has Improved Bioavailability Compared with the Conventional Micronized Formulation in the Fasting State." Drug Design, Development and Therapy Jun. 2014.

MLA (9th ed.) Citation

K, Jang, et al. "Novel Nanocrystal Formulation of Megestrol Acetate Has Improved Bioavailability Compared with the Conventional Micronized Formulation in the Fasting State." Drug Design, Development and Therapy, Jun. 2014.